NLRP3 and infectious disease: NLRP3 is a drug target of significant interest to the pharmaceutical industry, with potential for the treatment of several inflammatory diseases including cancer [9], autoimmune diseases [10], metabolic disorders [11], cardiovascular disease [12], CNS diseases [13], and infectious diseases including COVID-19 [14].